Article
Immuno-oncologic profiling of pediatric brain tumors reveals major clinical significance of the tumor immune microenvironment.
Nature communications - 10 Jul 2024
Levine Adrian B, Nobre Liana, Das Anirban, Milos Scott, Bianchi Vanessa, Johnson Monique, Fernandez Nicholas R, Stengs Lucie, Ryall Scott, Ku Michelle, Rana Mansuba, Laxer Benjamin, Sheth Javal, Sbergio Stefanie-Grace, Fedoráková Ivana, Ramaswamy Vijay, Bennett Julie, Siddaway Robert, Tabori Uri, Hawkins Cynthia
Abstract excerpt
With the success of immunotherapy in cancer, understanding the tumor immune microenvironment (TIME) has become increasingly important; however in pediatric brain tumors this remains poorly characterized. Accordingly, we developed a clinical immune-oncology gene expression assay and used it to profile a diverse range of 1382 samples with detailed clinical and molecular annotation. In low-grade gliomas we identify...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
